Events
-
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: Phase 3 PEAK study could usher in new second-line therapy for GIST
-
ASCO 2026: Personalised vaccine boosts immune activity against brain cancer
-
ASCO 2026: GLP-1s may reduce metastatic progression of certain obesity-related cancers
-
ASCO 2026: Yoga may help cancer survivors sleep better and reduce anxiety, fatigue
-
-
A simple intervention benefits cancer patients while saving hospitals money
Cancer patients who received specialised mental health support as part of their treatment plan are…
Researchers develop test that could identify precancerous lesions on the fallopian tubes
Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Gynecology and Obstetrics…
Study reveals drastic decline in cancer diagnoses during COVID-19 pandemic
Amid the unprecedented challenges posed by the COVID-19 pandemic, a comprehensive analysis published in the…
New research outlines a critical driver in an immune cell’s defence against melanoma
- Study suggests common drug could be used to prevent certain skin cancers
- AACR 2021: Unselected autologous tumour infiltrating lymphocyte therapy shows early promise in patients with metastatic melanoma
- AACR 2021: Immunotherapy response prediction using tumour mutational burden may differ between men and women with melanoma
Marine algae from the Kiel Fjord discovered as a remedy against infections and skin cancer
Healing with the help of marine organisms is no utopia. Already 12 life-saving drugs, e.g. against cancer, have been developed…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.